Esophageal cancer: patient evaluation and pre-treatment staging
- PMID: 11750229
- DOI: 10.1016/s0960-7404(01)00023-8
Esophageal cancer: patient evaluation and pre-treatment staging
Abstract
Improvements in the overall survival of patients with esophageal cancer can in the future only be achieved by tailored therapeutic strategies which are based on the individual histologic tumor type, tumor location, tumor stage at the time of presentation, consideration of established prognostic factors and the physiologic status of the patient. The major aim of every diagnostic strategy is to assess whether a complete macroscopic and microscopic tumor resection (i.e. an R0 resection) can be achieved by primary surgical approach with a high degree of likelihood. This requires histologic classification of the tumor type (squamous cell cancer or adenocarcinoma), the exclusion of distant solid organ metastases, localization of the primary tumor in relation to the tracheobronchial tree, and determination of the T-category and the surrounding structures of the primary tumor. This is currently achieved by a combination of contrast radiography, endoscopy with biopsy, endoscopic ultrasonography and CT scan. PET scanning will in the future be more widely used in esophageal cancer staging because it appears to be superior to current imaging modalities in the exclusion of distant solid organ and lymph node metastases and allows early assessment of response of the primary tumor to neoadjuvant treatment. Systematic risk analysis with a dedicated composite scoring system is essential to assess the physiologic status of the patient and reduce postoperative mortality. Only hospitals with a sufficient case load of esophageal cancer patients ('hospital volume') and a dedicated interest in the management of this disease ('centers of excellence') can provide the required expertise and standards for patient evaluation and tailored therapy.
Similar articles
-
Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification.Ann Surg. 2005 Nov;242(5):684-92. doi: 10.1097/01.sla.0000186170.38348.7b. Ann Surg. 2005. PMID: 16244542 Free PMC article.
-
[Staging and neoadjuvant therapy of squamous cell carcinoma of esophagus].Ther Umsch. 2001 Mar;58(3):165-73. doi: 10.1024/0040-5930.58.3.165. Ther Umsch. 2001. PMID: 11305155 Review. German.
-
International survey on esophageal cancer: part II staging and neoadjuvant therapy.Dis Esophagus. 2009;22(3):203-10. doi: 10.1111/j.1442-2050.2008.00930.x. Epub 2009 Jan 23. Dis Esophagus. 2009. PMID: 19191855
-
[Management of esophageal squamous cell carcinoma and adenocarcinoma: surgical, endoscopic, and radiotherapeutic options].Med Clin (Barc). 2012 Dec 1;139(13):588-92. doi: 10.1016/j.medcli.2012.05.024. Epub 2012 Jul 28. Med Clin (Barc). 2012. PMID: 22841469 Review. Spanish. No abstract available.
-
Treatment of clinical T2N0M0 esophageal cancer.Ann Surg Oncol. 2014 Nov;21(12):3739-43. doi: 10.1245/s10434-014-3929-6. Epub 2014 Jul 22. Ann Surg Oncol. 2014. PMID: 25047477
Cited by
-
Prevention and management of early esophageal cancer.Curr Treat Options Oncol. 2004 Oct;5(5):405-16. doi: 10.1007/s11864-004-0030-6. Curr Treat Options Oncol. 2004. PMID: 15341678 Review.
-
[Preoperative evaluation of prognostic factors in esophageal squamous cell cancer].Chirurg. 2005 Nov;76(11):1011-7. doi: 10.1007/s00104-005-1109-8. Chirurg. 2005. PMID: 16247636 German.
-
The role of integrated F-18-FDG-PET scanning in the detection of M1 disease in oesophageal adenocarcinoma and impact on clinical management.J Gastrointest Surg. 2011 Dec;15(12):2127-35. doi: 10.1007/s11605-011-1686-4. Epub 2011 Oct 1. J Gastrointest Surg. 2011. PMID: 21964582
-
Adenocarcinoma of the esophagus and the esophagogastric junction: positron emission tomography improves staging and prediction of survival in distant but not in locoregional disease.J Gastrointest Surg. 2004 Dec;8(8):988-96. doi: 10.1016/j.gassur.2004.09.040. J Gastrointest Surg. 2004. PMID: 15585386
-
Superficial esophageal lesions detected by endoscopic ultrasound enhanced with submucosal edema.World J Gastroenterol. 2013 Dec 21;19(47):9034-42. doi: 10.3748/wjg.v19.i47.9034. World J Gastroenterol. 2013. PMID: 24379628 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical